NCI Funding Announcements and Notices for COVID-19
NCI is providing funding for research on COVID-19 and revising certain existing grants and cooperative agreements to make funds available to help address the public health crisis. New funding notices will be added to this page as they become available.
Number | Title | Release Date | Expiration Date |
---|---|---|---|
NOT-MD-20-025 | Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities | 08/13/2020 | 05/08/2023 |
NOT-CA-20-054 | Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis | 04/28/2020 | |
PA-20-135 | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | 03/10/2020 | 09/08/2025 |
Number | Title | Release Date | Expiration Date |
---|---|---|---|
NOT-CA-20-048 | Notice of National Cancer Institute (NCI) Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" | 04/03/2020 | 01/25/2022 |
NOT-OD-20-129 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project | 06/25/2020 | 07/13/2021 |
NOT-CA-21-033 | Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control | 02/03/2021 | 04/01/2021 |
RFA-OD-20-018 | Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) | 08/06/2020 | 09/19/2020 |
RFA-OD-20-014 | Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) | 08/06/2020 | 09/16/2020 |
NOT-CA-20-082 | Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) | 07/06/2020 | 08/15/2020 |
NOT-CA-20-077 | Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers | 06/25/2020 | 07/16/2020 |
NOT-OD-20-121 | Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | 06/12/2020 | 08/07/2020 |
NOT-OD-20-120 | Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | 06/12/2020 | 08/07/2020 |
NOT-OD-20-119 | Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | 06/12/2020 | 08/07/2020 |
RFA-OD-20-013 | Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) | 06/12/2020 | 08/07/2020 |
RFA-CA-20-039 | Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) | 06/05/2020 | 07/22/2020 |
RFA-CA-20-038 | Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) | 06/05/2020 | 07/22/2020 |
NOT-CA-20-066 |
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence |
05/15/2020 | |
NOT-CA-20-065 | Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences | 05/14/2020 | 05/26/2020 |
NOT-CA-20-042 | National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) | 04/10/2020 | 06/26/2020 |
NOT-CA-20-043 | National Cancer Institute Announcement Regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) | 04/09/2020 | 06/26/2020 |